This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Treatment of MODY

Authoring team

treatment

seek expert advice.

GCK - MODY

  • general consensus is that the majority of these patients do not require treatment since insulin or oral hypoglycaemic agents has little effect on glycemia in this group
  • however in pregnancy insulin may be required to prevent excess fetal growth

HNF1A-MODY and HNF4A-MODY

  • low dose sulfonylureas are recommended as first line treatment for patients with HNF1A/HNF4A-MODY, however most patients will progress to insulin treatment with time
  • a short-acting sulfonylurea such as nateglinide may sometimes be used as an alternative

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.